The plasma concentration of each drug was measured by LC-MS/MS based on the ESI (electrospray ionization) method. The LC-MS/MS system consisted of a high-performance liquid chromatograph LC-30AD system (Shimadzu, Kyoto, Japan) and an AB Sciex QTRAP 6500 tandem mass spectrometer (Framingham, MA, USA). Capcell Pak C18 MGII (particle size 5 μm, inner diameter 2.0 mm x 50 mm; Osaka Soda, Osaka, Japan) was used as the separation column. To measure the concentration of SVA, solvent A (water containing 0.063% ammonium formate) and solvent B (acetonitrile) were used as the mobile phase. The gradient conditions were maintained at 20% solvent B for 1.5 min, increased from 20% to 95% solvent B in 1.50 min, held at 95% for 1.0 min, decreased back to 20% within 0.01 min, and held at 20% for 1.49 min. To measure the concentration of LEV and CBZ, solvent A (water containing 0.1% formic acid) and solvent B (acetonitrile) were used as the mobile phase. The gradient conditions of LEV were increased from 5% to 60% solvent B in 1.50 min, sharply increased to 95% within 0.01 min, held at 95% for 1.49 min, decreased back to 5% within 0.01 min, and held at 5% for 1.49 min. The gradient conditions of CBZ were increased from 30% to 95% solvent B in 2.00 min, held at 95% for 1.00 min, decreased back to 30% within 0.01 min, and held at 30% for 1.49 min.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.